what are the disadvantages of oral semaglutide A Review in Adults with Overweight or Obesity (OASIS) Trials Evaluating Oral Semaglutide (Wegovy) for Chronic Weight Management in Adults With Overweight or Obesity Effectiveness of Oral versus Injectable

Most published human trials have used precursors (NR or NMN) rather than direct liposomal NAD+, and have measured blood NAD+ levels rather than functional endpoints like energy, recovery, or healthspan

While often cited as evidence that oral peptide delivery has become broadly feasible, a rigorous examination reveals the opposite

As a GLP-1 receptor agonist, semaglutide is typically well-tolerated and offers a reliable option to help patients reduce appetite, lower calorie intake, and achieve gradual, sustainable weight loss

They increase insulin when glucose levels are high, reduce glucagon, slow stomach emptying, and decrease hunger